Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.

[1]  V. Pecha,et al.  Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy , 2011, Cancer.

[2]  T. Julian,et al.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Sabel.  Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and cons. , 2010, Surgical oncology clinics of North America.

[4]  A. Giuliano,et al.  Axillary Staging in the Neoadjuvant Setting , 2010, Annals of Surgical Oncology.

[5]  M. Tunaci,et al.  Axillary sentinel node biopsy after neoadjuvant chemotherapy. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  G Villa,et al.  Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. Sagan,et al.  Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Nitti,et al.  A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial , 2008, Annals of surgery.

[9]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[10]  L. Newman,et al.  Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation , 2007, Annals of Surgical Oncology.

[11]  M. Ross,et al.  Feasibility and Accuracy of Sentinel Lymph Node Biopsy After Preoperative Chemotherapy in Breast Cancer Patients With Documented Axillary Metastases , 2007, Cancer.

[12]  Umberto Veronesi,et al.  Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. , 2006, The Lancet. Oncology.

[13]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[14]  Quan P. Ly,et al.  Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy , 2006, Annals of Surgical Oncology.

[15]  Gary H Lyman,et al.  Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma , 2006, Cancer.

[16]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Barbara L. Smith,et al.  A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. , 2005, American journal of surgery.

[18]  T. Julian,et al.  Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Julian,et al.  Accurate Axillary Nodal Staging Can be Achieved after Neoadjuvant Therapy for Locally Advanced Breast Cancer , 2004, The American surgeon.

[20]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[21]  D. Wickerham,et al.  The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[23]  E. Mamounas.  Sentinel lymph node biopsy after neoadjuvant systemic therapy. , 2003, The Surgical clinics of North America.

[24]  A. Giuliano,et al.  Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.

[25]  Umberto Veronesi,et al.  Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .

[26]  D. Mankoff,et al.  Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma , 2000 .

[27]  M. Ross,et al.  Identification and Evaluation of Axillary Sentinel Lymph Nodes in Patients With Breast Carcinoma Treated With Neoadjuvant Chemotherapy , 2000, The American journal of surgical pathology.

[28]  I. Smith,et al.  Neoadjuvant chemotherapy for breast cancer , 2000, Annals of medicine.

[29]  D. Mankoff,et al.  Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. , 2000, Cancer.

[30]  A. Luini,et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. , 1999, Journal of the National Cancer Institute.

[31]  Keshtgar.  Sentinel Lymph Node Biopsy in Carcinoma of the Breast , 1999 .

[32]  T. Powles,et al.  A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[34]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[36]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.